Neos Therapeutics Inc (NEOS) Return on Equity ROE from the third quarter 2020 to third quarter 2019 and annually, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neos Therapeutics Inc   (NASDAQ: NEOS)

Neos Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Neos Therapeutics Inc in the third quarter 2020?
Due to the lack of equity, it was not possible to calculate Neos Therapeutics Inc 's return on equity (ROE) in its third quarter 2020

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -22 -19 -17 -17 -23
Return On Equity (TTM) - - - - -2100.25 %
NEOS's Total Ranking # # # # #
Equity (TTM) in Millions -21 -16 -13 -6 -3
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to NEOS Management Effectiveness >> NEOS's 5 Years Annual ROE >> Compare NEOS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





NEOS Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions -6 8 8 -2 78
Y / Y Equity Change - -0.57 % - - -
Net Income in Millions -17 -52 -66 -83 -31
Y / Y Net Income Change - - - - -
Return On Equity - -658.7 % -839.63 % - -39.27 %

Back to NEOS Management Effectiveness >> NEOS's 5 Years Annual ROE >> Compare NEOS ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NEOS's' Return on Equity at Yahoo Finance
NEOS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NEOS's Competitors
Subscribers only: Roe for Neos Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for NEOS's Customers




Companies with similar Return On Equity at Sep 30 2020, within Healthcare Sector ROE
Vyne Therapeutics Inc   405.26 %
Hanger inc.  350.43 %
Abbvie Inc   204.66 %
Idexx Laboratories Inc  199.01 %
Xbiotech Inc   151.11 %
Eli Lilly And Company  146.99 %
Mettler toledo International Inc   142.98 %
Molecular Templates Inc   112.94 %
Co diagnostics Inc   102.14 %
Alpha Pro Tech Ltd   99.09 %
Integrated Biopharma Inc  94.28 %
American Renal Associates Holdings Inc   90.29 %
Coherus Oncology inc   88.44 %
Nrc Health  87.53 %
Sunlink Health Systems Inc   78.93 %
Amgen Inc   72.12 %
Vaso Corporation  70.24 %
Align Technology inc   68.99 %
Semler Scientific inc   67.37 %
Tenet Healthcare Corp  66.06 %
Catalyst Pharmaceuticals Inc   62.82 %
Innoviva Inc   62.32 %
Quidelortho Corp  56.48 %
Zoetis Inc   55.15 %
Biomx Inc  54.83 %
Retractable Technologies Inc  52.84 %
Zomedica Corp   51.31 %
Bio rad Laboratories Inc   49.89 %
Davita Inc   49.80 %
Hologic Inc  47.91 %

Date modified: 2026-09-08T15:10:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.